Previous Article | Next Article ![]()
Journal of Bacteriology, September 2007, p. 6109-6117, Vol. 189, No. 17
0021-9193/07/$08.00+0 doi:10.1128/JB.00246-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Institute of Molecular Biology, University of Oregon, Eugene, Oregon 97403,1 Department of Chemistry,2 Howard Hughes Medical Institute and Department of Molecular Biology, Princeton University, Princeton, New Jersey 085443
Received 14 February 2007/ Accepted 18 June 2007
|
|
|---|
28 (also called fliA), and the anti-sigma factor flgM—loss of luxS altered flagellar morphology. In all cases, the double mutant phenotypes were restored to the luxS+ phenotype by the addition of synthetic 4,5-dihydroxy-2,3-pentanedione (DPD), which cyclizes to form AI-2. Furthermore, in all mutant backgrounds loss of luxS caused a decrease in transcript levels of the flagellar regulator flhA. Addition of DPD to luxS cells induced flhA transcription in a dose-dependent manner. Deletion of flhA in a wild-type or luxS mutant background resulted in identical loss of motility, flagella, and flagellar gene expression. These data demonstrate that AI-2 functions as a secreted signaling molecule upstream of FlhA and plays a critical role in global regulation of flagellar gene transcription in H. pylori. |
|
|---|
A quorum-sensing system that is widespread across the bacterial kingdom and has been proposed to function as a "bacterial Esperanto," uses a collection of molecules collectively called AI-2 (4). AI-2-dependent processes include biofilm formation, motility, and type III secretion (18). AI-2 is synthesized by the LuxS protein (47), and luxS genes have been identified in at least 250 bacterial genomes to date (50). LuxS functions to cleave S-ribosylhomocysteine, an intermediate in the S-adenosylmethionine (SAM) pathway, into homocysteine and 4,5-dihydroxy-2,3-pentanedione (DPD) (40). Through processes of dehydration and cyclization, DPD exists in equilibrium with several molecules, some or all of which function as the molecular signal AI-2 (40). AI-2 has been extensively studied in Vibrio harveyi, where it has been shown to regulate bioluminescence and other traits (5, 20, 21, 28), and a V. harveyi reporter strain that expresses bioluminescence in response to the addition of AI-2 has become the standard method for detecting AI-2 production by other bacterial species (3).
Although AI-2 production is common among bacterial species, it remains controversial as to how many of these bacteria utilize AI-2 as a signaling molecule, as opposed to producing it as a metabolic by-product of the SAM pathway (15, 50). One such controversial case is Helicobacter pylori, a gram-negative pathogen of the human stomach. Two independent groups demonstrated that H. pylori secretes AI-2 into its extracellular environment by a luxS-dependent mechanism (19, 25). A subsequent study reported that an H. pylori luxS mutant exhibited reduced production of the flagellin protein FlaA and reduced expression of an flaA transcriptional reporter construct (29). In addition, an H. pylori luxS mutant is reported to form biofilms more efficiently than wild-type cells (10). Recently, two groups reported that mutation of the luxS genes in H. pylori strains SS1 and TK1402 exhibited motility defects on soft agar plates and colonization defects in mouse and gerbil models of infection, respectively (27, 37). However, Lee et al. found that a luxS mutant in a third H. pylori strain, X47, did not exhibit these defects. Based on the phenotypic variability they observed between strains, these authors concluded that luxS mutant phenotypes were the result of fitness defects due to the disruption of the SAM metabolic pathway, and they argued that AI-2 was unlikely to function as a quorum-sensing molecule in H. pylori. Evidence for a signaling function for AI-2 would require a demonstration that purified extracellular AI-2 is sufficient to reverse a luxS-associated phenotype. To date, besides the demonstration that AI-2-containing cell-free supernatant could modestly increase flaA reporter gene expression (29), no such evidence has been reported.
The possibility that H. pylori flagellar gene expression is regulated by an extracellular signaling molecule is intriguing in light of a long-standing proposal that H. pylori may regulate the composition of its flagellar filament in response to environmental cues (44). Unlike the regulation of flagellar gene expression in the model organisms Salmonella and Caulobacter crescentus, in which a single master regulator controls transcription of an entire hierarchy of genes in response to signals such as growth phase, in H. pylori the top-tier regulators of flagellar gene transcription, as well as chemotaxis- and motor protein-encoding genes, are constitutively expressed under the control of the housekeeping sigma factor,
80, and are referred to as class 1 genes (36). Class 2 genes are controlled by
54 (RpoN) and contain "middle" structural flagellar genes that encode components of the rod, hook, and sheath and the minor flagellin FlaB. Class 3 genes are controlled by
28 (FliA) and the anti-sigma factor FlgM (11, 24), and this group contains "late" flagellar structural genes such as the major flagellin FlaA. A final intermediate class, including both structural and regulatory genes, is controlled by both
54 and
28 (36). The closest candidate for a master regulator in this hierarchy is FlhA, a component of the basal body export apparatus, that is required for flagellum formation and for expression of most class 2 and class 3 genes and the intermediate class of flagellar genes (36, 41). A possible point through which environmental signals could be channeled into the flagellar transcriptional hierarchy is the unconventional cytoplasmic sensor kinase FlgS (HP0244), which coregulates
54-dependent genes of class 2 and the intermediate classes (6, 36).
Motility is an important prerequisite for H. pylori colonization of the stomach, as has been demonstrated for mutants lacking flagellar genes in multiple animal models (reviewed in reference 38). Thus, dissecting regulation of motility in H. pylori is important for understanding this pathogen's virulence strategies. By characterizing flagellar morphology and flagellar gene transcription in wild-type, luxS mutant, and AI-2-supplemented cells lacking key flagellar regulators, we demonstrate that AI-2 signaling influences the flagellar regulon through modulation of the transcription of the top-tier regulator gene flhA. Our data provide strong support for the model that H. pylori uses AI-2 as an intercellular signaling molecule.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Strains used in this study
|
luxS, luxS*, and flagellar mutant strains.
All primers used for strain construction are given in Table 2. The luxS gene (HP0105) was PCR amplified using the primers LuxSSpeR and LuxSEcoF and ligated into the TOPO vector using a TOPO TA cloning kit (Invitrogen Life Technologies, Carlsbad, CA) to create the vector pBR003. The primers TopoXbaF and TopoBlgR were used to amplify outward from HP0105 and around pBR003. A kan-sacB construct (12) encoding kanamycin resistance (Kanr) and sucrose sensitivity (Sucs) was PCR amplified using the primers FBglIIpKan+ and PFA3 (12). The pBR003 and Kan-SacB PCR products were digested and ligated together to make the vector pBR007. pBR007 was purified and used to disrupt the HP0105 locus in strain G27 through natural transformation and selection of Kanr colonies. The resulting luxS::kan-sacB strain was verified by PCR and sequencing of the genomic locus. To create the
luxS deletion strain, a deletion construct consisting of 265 bp immediately 5' of the HP0105 open reading frame fused to 255 bp 3' of HP0105 was created by PCR amplifying these sequences from G27 genomic DNA and then stitching them together in a subsequent PCR using primers listed in Table 2. This PCR product was used to transform the luxS::kan-sacB mutant strain, and Sucs colonies were isolated and validated as above. The luxS gene is not located in an apparent operon in either of the two H. pylori strains for which the genome has been sequenced (1, 49), and thus the
luxS deletion is unlikely to have polar effects. |
View this table: [in a new window] |
TABLE 2. Primers used for cloning and RT-PCR
|
luxS chromosome, as described previously (43). PCR products corresponding to the first 56 bp of the rdxA gene, 988 bp of the full-length luxS gene (including 265 bp of upstream sequence), and the final 94 bp of the rdxA gene were amplified in three separate PCRs and then stitched together in two subsequent PCRs using the primers listed in Table 2. The final PCR product was used to disrupt the rdx locus of
luxS by selecting for metronidazole-resistant colonies, which were validated as above. The flhA (HP1041) gene was amplified using the FlhAXho2 and FlhABgl2 primers and ligated into the TOPO vector using a TOPO TA cloning kit (Invitrogen Life Technologies, Carlsbad, CA) to create the vector KHR1. A Kanr nonpolar cassette with two internal ribosomal binding sites from pUC18 K-2 to ensure expression of downstream genes (33) was used to disrupt the flhA locus. The Kanr nonpolar cassette was amplified by the primers M13Asc1 and M13Nhe1, digested along with KHR1, and ligated into the vector. The flhA::Kanr construct was PCR amplified and introduced into the flhA locus through natural transformation. The flgS (HP0244), flgM (HP1122), and fliA (HP1032) mutants were all constructed using the Kanr nonpolar cassette as described previously (35). In each case the 5' and 3' ends of the flagellar gene and Kanr nonpolar cassette were PCR amplified in separate reactions and then stitched together in two subsequent PCRs using primers listed in Table 2.
Motility assays. Motility assays were performed on 0.4% agar plates consisting of Brucella broth, 0.02 mg ml–1 ß-cyclodextrin (Sigma), 8 mg ml–1 amphotericin B (Sigma), and 20 µg ml–1 vancomycin (Sigma). Plates were seeded with 1 µl of liquid culture grown to an optical density at 600 nm (OD600) of 1.0, corresponding to early stationary phase growth (24 h as shown in Fig. 1), and incubated for 5 to 8 days under microaerophilic conditions. The area of outward migration was recorded with a digital camera and calculated relative to a standard size reference area on the plate using Metamorph imaging software.
|
View larger version (9K): [in a new window] |
FIG. 1. AI-2 production in H. pylori is luxS dependent. AI-2 production in the wild-type strain G27 (A), the luxS mutant (B), and the complemented luxS* strain (C) was measured as the ability of CFS harvested at the indicated times after inoculation of liquid H. pylori cultures to induce bioluminescence in the V. harveyi reporter strain BB170 (relative light units [RLU]; bars). The cell densities of the cultures across the growth curves were determined by viable plate counts (CFU/ml; diamonds). Error bars indicate standard deviations of triplicate or duplicate samples for the bioluminescence and cell density measurements, respectively.
|
AI-2 complementation experiments.
To test for complementation of the
luxS motility phenotype, soft agar plates consisting of 0.4% agar were made using 70% BB medium and 30% CFS collected from wild-type or
luxS cultures at an OD600 of 1.0. Synthetic DPD was prepared as described previously (42). DPD activity was quantified with the V. harveyi BB170 bioassay and compared to CFS from wild-type H. pylori cultures grown to an OD600 of 1.0, the point in the growth curve at which we measured maximal AI-2 activity. DPD was added to H. pylori liquid cultures of various genotypes to a final concentration of 0.01 mM, 0.1 mM, or 1.0 mM. Cultures were incubated for 4 h, after which RNA was extracted or bacterial cells were visualized by transmission electron microscopy (TEM).
RNA collection and extraction. RNA was collected from H. pylori strains grown in BB medium to an OD600 of 1.0. Cells were passed onto 0.45-µm-pore-size cellulose nitrate membrane filters (Whatman, Maidstone, England) by vacuum. Filters were placed in 50-ml conical tubes and stored at –80°C. To extract RNA, filters were thawed on ice, appropriate amounts of Trizol were added, and RNA was extracted following the manufacturer's instructions (Gibco). Contaminating genomic DNA was removed using a Turbo DNA Free kit (Ambion).
RT-PCR.
Primers used for reverse transcription-PCRs (RT-PCRs) are listed in Table 2. All RT reactions were performed using 1 µg of RNA, Superscript II (Invitrogen), and gene-specific primers, and mixtures were incubated for 50 min at 42°C. Quantitative RT-PCR (qRT-PCR) reaction mixtures contained 5 µl of cDNA template, gene-specific primers, 12.5 µl of SYBR Green Master Mix (Applied Biosystems), and distilled H20 to a 25-µl total volume. qRT-PCR assays were performed in triplicate with an ABI Prism 7900HT Sequence Detector (Applied Biosystems). Transcript levels were normalized to ureA or the 16S rRNA gene in each sample (using 
CT analysis as described in ABI User Bulletin 2, available at http://docs.appliedbiosystems.com/pebiodocs/04303859.pdf). The ureA transcript was chosen for normalization because it amplified consistently across different genotypes at the same growth phase. The flhA mutants were an exception in that they expressed reduced levels of ureA transcript, consistent with a previous report implicating flhA in regulation of ureA transcription (32); for these mutants the 16S rRNA gene was chosen for normalization, using primer sequences 1320f and 1431r as described previously (13). Other primers used for qRT-PCR were designed using Primer Express software (Applied Biosystems); all primer sequences are listed in Table 2.
TEM. All samples for TEM were grown overnight in BB medium from a starting OD600 of 0.02. A 10-µl sample of each strain was applied to copper grids (400 mesh) with Butvar support film coated with carbon, rinsed twice, and negatively stained for 1 min with 1% phosphotungstate (pH 6.97). Grids were visualized and photographed in a Philips CM12 TEM at an acceleration voltage of 80 kV. Bacterial counts for each genotype and treatment group were conducted on three separate grids, counting a minimum of 100 cells, for at least two independent experiments.
|
|
|---|
luxS strain). To verify that any phenotypes we observed with the
luxS strain were due to the loss of the luxS gene product, we constructed a genetically complemented strain (hereafter referred to as the luxS* strain) by placing the full-length luxS gene and upstream sequences in the
luxS mutant chromosome at the rdx locus, which encodes a nonessential gene that, when mutated, results in metronidazole resistance without causing a growth disadvantage (2, 43). We isolated CFS from wild-type,
luxS, and luxS* cultures at different time points during growth in liquid medium and assayed their abilities to induce bioluminescence when incubated with the V. harveyi reporter strain BB170. The wild-type strain produced AI-2 in a growth-stage-dependent manner, with significant AI-2 activity accumulating during stationary phase (Fig. 1A). The
luxS mutant, unlike the wild-type parent strain, was not able to activate bioluminescence (Fig. 1B, note difference in y-axis scale). The luxS* strain activated bioluminescence in the reporter at levels higher than the wild-type strain (Fig. 1C), suggesting that the insertion of the luxS gene and its promoter at a heterologous position in the chromosome resulted in elevated expression of the gene product. The complementation experiment confirmed that LuxS is responsible for AI-2 production in H. pylori. Neither the interruption of the luxS gene nor the insertion of luxS at the rdx locus caused any growth defect under the conditions examined (Fig. 1).
The
luxS mutant has reduced motility.
Based on the report that luxS may regulate flaA expression (29), we measured motility of the H. pylori wild-type,
luxS, and luxS* strains. Liquid bacterial cultures growing at early stationary phase were spotted onto the center of soft agar plates and incubated for 6 days, and the resulting swarm halo areas were quantified. The
luxS mutant consistently produced a reduced swarm halo compared to the wild-type strain in repeated trials (one representative trial is shown in Fig. 2). Interestingly, the luxS* strain, which produces higher levels of AI-2 than the wild type (Fig. 1), also produced a larger swarm halo than the wild-type strain. To test whether the
luxS motility defect could be complemented by a secreted factor produced by wild-type but not
luxS mutant cells, we prepared soft agar plates composed of 70% fresh BB medium and 30% CFS from each strain. Both the wild-type and luxS* strains formed halos approximately 25% smaller when grown on wild-type CFS-supplemented plates than on normal medium (Fig. 2), which could be due to AI-2, depletion of an essential nutrient, or to the presence of a noxious by-product of bacterial metabolism in the spent medium, or a combination of all three. Both strains formed halos approximately 50% smaller when grown on
luxS CFS relative to normal medium, which could be due to similar noxious effects of the wild-type CFS without the positive effect of AI-2 or to differences in the chemical composition of the CFS from the two strains, as illustrated by the global metabolic difference between wild-type and
luxS E. coli (51). Notably, the
luxS mutant formed halos over 600% larger on wild-type CFS-supplemented plates than on normal medium or
luxS CFS-supplemented plates (Fig. 2). These data indicate that a substance in the wild-type but not
luxS CFS, likely AI-2, can complement the motility defect of the
luxS mutant.
![]() View larger version (28K): [in a new window] |
FIG. 2. The luxS mutant has a motility defect that is rescued by wild-type CFS. Wild-type, luxS, and luxS* bacteria were seeded onto soft agar plates composed of normal medium or supplemented with CFS from wild-type or luxS cultures. After 6 days of incubation, the halos of migration were visualized (A) and quantified (B). Error bars indicate the standard deviation of halo sizes of triplicate cultures in one experiment.
|
luxS mutant, and luxS* strains. In cell populations of all three genotypes, the flagella appeared normal, as scored for at least 100 cells per genotype (Fig. 3A to D). We reasoned, however, that the flagellum might be especially sensitive to the presence of AI-2 in genetic backgrounds in which its integrity was already compromised. To test this idea, we constructed mutations in four key flagellar regulators in both the wild-type and the
luxS mutant genetic backgrounds. Using a nonpolar cassette designed to allow translation of downstream genes in the operon (33), we created insertion mutations in flgS (HP0244), encoding the sensor kinase that regulates class 2 and the intermediate class gene transcription (6, 36); in fliA, the
28 responsible for class 3 and the intermediate class gene expression; in flgM, the anti-sigma factor for fliA (11, 24); and in flhA, the flagellar master regulator (36, 41). All flagellar single and
luxS double mutants were tested for motility on soft agar plates. In all cases, the mutants were nonmotile, as expected based on previous reports, with no differences between the single and double mutants (data not shown).
![]() View larger version (146K): [in a new window] |
FIG. 3. AI-2 modulates flagellar morphogenesis. Representative flagella, as visualized by TEM, are shown for each of the genotypes indicated grown in normal medium (A to C, E, F, I, J, M, and N) or for 4 h in the presence of 0.1 mM DPD (G, K, and O). In all cells with flagella, the base is marked by an arrow, and the tip is marked by an arrowhead. Scale bars, 1 µm. The flagellar morphologies were scored for at least 100 cells for each treatment group (D, H, L, and P).
|
luxS double mutants had phenotypes that differed from the single mutant phenotypes as described below. The results for one representative experiment are shown in Fig. 3. The flgS single mutant did not produce any flagella (Fig. 3E), as reported previously (36). In contrast, 36% of the flgS
luxS double mutant population produced truncated flagella (Fig. 3F and H). The fliA single mutant exhibited truncated flagella (Fig. 3I), as has been previously described (11, 24). In the fliA
luxS double mutant population, the proportion of cells completely lacking flagella increased, with a corresponding decrease in the fraction of cells carrying truncated flagella (Fig. 3J and L). As previously reported, the flgM single mutant produces abnormally long flagella (11), and a small proportion displays ectopic flagella at both cell poles (24) (Fig. 3 M). In contrast, the majority of the flgM
luxS double mutant cells exhibited truncated flagella (Fig. 3N and P). As previously reported, the flhA mutant did not produce flagella (41). The flhA
luxS double mutant cells were also completely aflagellated (data not shown).
To test whether the flgS
luxS, fliA
luxS, and flgM
luxS double mutant flagellar phenotypes were due to the loss of AI-2 signaling, we treated each of the double mutant cultures with synthetic DPD, which spontaneously converts to AI-2. For these experiments we used a final concentration of 0.1 mM DPD that corresponded to the maximal concentration of AI-2 produced by H. pylori cultures (see Fig. 4C). Cultures were incubated with DPD for 4 h and visualized by TEM. In all cases, the addition of DPD completely reversed the
luxS double mutant flagellar phenotypes (Fig. 3G, K, and O). These results demonstrate that AI-2, acting as an extracellular signal, modulates flagellar morphogenesis.
![]() View larger version (33K): [in a new window] |
FIG. 4. AI-2 modulates flagellar gene transcription. Transcript levels of flgS, fliA, flgM, and flaA (A) and of flhA (B) were determined by qRT-PCR normalized to the levels of ureA in each of the genotypes indicated and are represented as the log2 difference relative to the levels in the wild-type strain. Levels of the same transcripts were determined in the indicated genotypes and normalized to the levels of the 16S rRNA gene in each sample (C). AI-2 activity in CFS from wild-type early-stationary-phase H. pylori was measured relative to different concentrations of DPD (D). flhA transcript levels were measured as in panel B in wild-type and luxS cultures untreated or treated for 4 h with 0.1 mM DPD (E) and in luxS cultures treated with a range of DPD concentrations (F). Error bars indicate the standard deviations for three triplicate samples.
|
luxS mutants, we used semiquantitative RT-PCR to screen for alterations in gene expression of representative genes of the four flagellar classes in the 10 genotypes described above. The genes that showed marked differences in transcript levels between the genotypes were reanalyzed by qRT-PCR in an independent experiment. Transcript abundances were normalized to ureA, which displayed consistent levels across the different genotypes at the same growth phase. The flhA and flhA
luxS mutants were exceptions and exhibited marked reduction in ureA transcription, consistent with a previous report of reduced urease activity in flhA mutants (32); for these mutants 16S rRNA transcript was used for normalization. The class 1 genes involved in chemotaxis and motor function (cheW, cheA, motA, motB, tlpA, and hpaA, encoding a flagellar sheath-associated protein) did not exhibit differences in expression levels between the genotypes. In contrast, dynamic changes were observed across the genotypes in multiple genes involved in flagellar biosynthesis, including genes regulated by all three sigma factors (Fig. 4A). The transcriptional differences between the various mutants demonstrate the complexity of the flagellar gene transcription hierarchy and its sensitivity to perturbations. For example, the flgS
luxS double mutant, which formed some truncated flagella in contrast to the aflagellated flgS mutant, exhibited elevated levels of flaA transcript encoding the major flagellin. Whereas elimination of flgS in a
luxS background derepressed flagellar production, flgS levels were elevated in both the fliA
luxS and flgM
luxS double mutants relative to the luxS+ single mutants. We note that elevation of flgS transcription was associated with loss or truncation of flagella in the double mutants, suggesting a role for FlgS as a negative regulator of flagellar biosynthesis.
Notably, the top tier regulator flhA showed a consistent pattern of reduced transcription in the
luxS genotypes (Fig. 4B). We demonstrated that flhA was required for expression of the flagellar genes flgS, fliA, flgM, and flaA (Fig. 4C), confirming its role as a key activator of the flagellar regulon. The flhA
luxS double mutant exhibited a pattern of flagellar gene transcription identical to that of the flhA single mutant (Fig. 4C). To test whether loss of AI-2 signaling could account for the reduction in flhA transcript in the flgS
luxS, fliA
luxS, and flgM
luxS double mutants, we added back an equivalent amount of synthetic DPD to
luxS cultures to restore the normal level of AI-2 in the medium. To do this, we compared the level of AI-2 activity in CFS derived from early stationary phase wild-type H. pylori, which we had shown to produce maximal AI-2 (Fig. 1A), to various concentrations of synthetically prepared DPD. We found that a 0.1 mM concentration of DPD and wild-type CFS caused roughly equivalent levels of expression of bioluminescence in the V. harveyi BB170 reporter strain (Fig. 4D). Indeed, incubation of the
luxS mutant with this concentration of DPD was sufficient to restore flhA transcript levels to that of wild-type cells (Fig. 4E). Furthermore, exposure of wild-type cells to 0.1 mM DPD resulted in elevated flhA transcript levels (Fig. 4E). To further characterize the dose responsiveness of flhA transcription to AI-2, we exposed
luxS mutant cultures, which are devoid of endogenous AI-2, to a range of DPD concentrations. flhA transcript levels increased in a dose-dependent manner between 0.01 and 0.1 mM DPD (Fig. 4F). No additional increase in flhA transcript levels was observed at 1 mM DPD, suggesting that the effects of DPD on flhA transcription were saturable or possibly even inhibitory. These data show that AI-2 alone is sufficient to modulate flagellar gene expression in a dose-dependent manner.
|
|
|---|
luxS mutant phenotype could be due to a defect in the morphogenesis or function of the motility apparatus. We observed no abnormalities in the morphology of the
luxS mutant flagella by TEM or of the luxS* strain that produces elevated levels of AI-2, and the mutant cells were motile when observed in wet mount, although we did observe some differences in their swimming behavior, which is the focus of a separate study (B. A. Rader and K. Guillemin, unpublished data). However, when we deleted the luxS gene in mutants lacking any of three key flagellar regulatory genes—the sensor kinase flgS, the flagellar sigma factor fliA, and its anti-sigma factor, flgM—we observed strikingly different flagellar phenotypes in the double versus the single mutants. All of the double mutant phenotypes were reversed to that of the luxS+ single mutants by the addition of purified AI-2, indicating that the regulation of flagellar morphology is mediated by this extracellular signal. We confirmed flhA's role as a top-tier regulator of flagellar gene transcription and demonstrated that an flhA mutant and an flhA
luxS double mutant had identical phenotypes, consistent with the idea that the AI-2 signal acts upstream of FlhA. We further demonstrated that purified AI-2 is sufficient to induce expression of flhA.
Our finding that AI-2 regulates flagellar gene expression in H. pylori argues that this molecule functions as an intercellular signaling molecule in this species. In addition, our data suggest that AI-2 signaling regulates motility, as indicated by our finding that wild-type but not
luxS CFS can restore spreading of
luxS mutants on soft agar plates. It is unlikely, however, that AI-2 regulation of flagellar gene expression explains the motility defect of the
luxS mutants, given the similarity in the wild-type and mutant flagellar morphologies. Our data do not rule out additional metabolic requirements for luxS in this species that could explain the colonization defects observed with luxS mutant H. pylori strains (27, 37). The finding that a luxS mutant in the X47 strain did not exhibit motility or colonization defects (27) indicates that AI-2 signaling or LuxS metabolic activities are not required in all H. pylori strains, reflecting a phenotypic heterogeneity in this species that we have also observed (2).
Integration of environmental signals into the flagellar gene transcription hierarchy.
Our genetic and molecular data suggest a model, shown in Fig. 5, in which AI-2 regulates flagellar morphology by influencing initial steps in the flagellar gene transcription hierarchy. Consistent with the model that the AI-2 signal functions exclusively upstream of FlhA, we observed identical phenotypes in the flhA single and flhA
luxS double mutants in their lack of motility and flagella and reduced expression of flagellar genes. In contrast, the flagellar morphology of the
luxS double mutants in combination with flagellar regulators in parallel pathways that branch downstream of FlhA differed from those of the corresponding single mutants, consistent with the model that the AI-2 signal functions both upstream and in parallel to FlgS, FliA, and FlgM. In addition, our finding that AI-2 is sufficient to activate expression of flhA places it upstream of this top-tier flagellar regulator.
![]() View larger version (10K): [in a new window] |
FIG. 5. Model of AI-2 modulation of the H. pylori flagellar regulon. The role of AI-2 in transcriptional regulation of components of the flagellar gene hierarchy of H. pylori is shown, based on Neihus et al. (36). AI-2 signals upstream of FlhA, which, in turn, regulates branching pathways of gene transcription regulated by FlgS, FlgM, and FliA/ 28.
|
luxS and flgM
luxS mutants correlated with shorter flagella than with the luxS+ genotypes. All three regulators were also required for wild-type levels of flhA expression, and their effects were at least additive with that of luxS. Since flhA is required for expression of most of the flagellar gene regulon (36), AI-2 regulation of flhA transcription is likely to contribute to the differences in flagellar gene expression and flagellar morphology observed in the different
luxS mutants, although the complexity of this regulatory network and the importance of posttranscriptional regulatory events make it difficult to formulate specific predictions about the consequence of reducing flhA levels in each mutant background analyzed. Our finding that AI-2 itself is sufficient to increase flhA transcript levels in a dose-dependent manner represents a new signal that can influence H. pylori flagellar biosynthesis. Multiple complex and diverse hierarchical regulatory pathways of flagellar gene expression have been described in bacteria (31), many of which are regulated by master regulators whose expression is, in turn, influenced by environmental conditions such as nutrient availability and cell cycle (7, 30). In several systems, AI-2 has been implicated in regulating flagellar biosynthesis. An luxS mutant of Campylobacter jejuni, a close relative of H. pylori, also exhibits decreased motility on soft agar plates and regulates flaA expression in an luxS-dependent manner (17, 23). Treatment of Escherichia coli strain K-12 with purified AI-2 has been shown to increase this bacterium's motility on soft agar plates through a mechanism that involves a novel motility quorum-sensing regulator, MqsR, regulating qseBC and flhDC expression (22).
Environmental regulation of H. pylori flagellar morphogenesis.
Motility is an absolute requirement for H. pylori colonization in several animal models (16, 38, 39) and is thus considered an important virulence trait of this pathogen. Little is known, however, about the regulation of H. pylori flagellar biosynthesis within the gastric environment. Unlike the flagellar gene hierarchies of the enteric Gammaproteobacteria or Caulobacter, which possess the master regulators FlhCD and CtrA, respectively, responsible for all flagellar gene expression, many of the H. pylori flagellar and chemotaxis genes (the class 1 genes) are under the control of the housekeeping sigma factor,
80, and are constitutively expressed (36). Environmental factors, however, clearly modulate expression of flagellar genes. Growth of H. pylori in acidic medium induces expression of many of the class 2 and intermediate genes and is associated with increased motility (34), whereas growth on cultured gastric epithelial cells represses expression of the class 3 gene flaA (26). flaA expression increases in the switch from exponential growth to stationary phase (48), during the period when we observe significant AI-2 accumulation, and AI-2-containing CFS induces transcription of an flaA reporter (29). We report here that AI-2 regulates expression of the class 1 gene flhA and influences flagellar morphogenesis. In addition, the transcript levels of another class 1 gene, flgS, fluctuated dramatically between the different genotypes we analyzed, indicating that expression of these top-tier regulators is sensitive to concentrations of an environmental signal.
H. pylori may use AI-2, which we have shown it produces in a cell density-dependent manner, in conjunction with other environmental cues to regulate flagellar structures as a survival strategy within the human stomach. At high cell densities and high AI-2 concentrations, it may be beneficial for H. pylori to increase flagellum production as a strategy to promote motility and dispersal throughout the stomach. Also, despite the textbook picture of the stomach as devoid of bacteria, a recent 16S rRNA enumeration study demonstrated a diverse gastric microbiota (8), which may contribute to AI-2 levels in the stomach and influence H. pylori motility in this habitat. Patterns of H. pylori dispersal within the gastric environment are correlated with disease outcome: ulcers are associated with concentrated bacterial populations in the distal stomach and gastric cancer arises from infections in which the bacteria are distributed throughout the stomach (9). An understanding of the environmental cues, both bacterial and host derived, that regulate H. pylori flagellar morphogenesis in the human stomach will contribute to our ability to predict and control H. pylori-associated disease outcomes.
luxS mutants; David Baltrus, Kevin Bourzac, and Kyle Mouery for help with genetic manipulations of H. pylori; and the entire Guillemin laboratory for helpful discussions. K.G. is a recipient of a Burroughs Wellcome Fund Career Award in the Biomedical Sciences and was supported by Research Scholar Grant RSG-03-101-01-MBC from the American Cancer Society and NIH grant R56 DK075667-01. B.L.B. is funded by the NIH, NSF, and HHMI.
Published ahead of print on 22 June 2007. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»